[1] 王继军,张明岛.精神分裂症的DUP[J]. 上海精神医学, 2005, 17 (6):356-359. [2] 盖海军, 朱志启, 吴景欢,等. 首发精神分裂症患者精神病治疗前期间影响因素与临床疗效关系的流行病学研究[J]. 中华行为医学与脑科学杂志, 2010, 19(7):591-594. [3] 秦虹云, 张洁, 王振萍,等. 首发精神分裂症未经治疗时间与临床疗效间关系:4年随访研究[J]. 上海精神医学, 2014, 26(1):42-48. [4] WHO. Intemational statistical classification of diseases and related health problems[M]. 10th ed. Geneva:World Health Organization,2010. [5] 王继军, 朱紫青. 精神分裂症未治期及其影响因素研究[J]. 上海精神医学, 2009, 21 (1):10-13. [6] Lieberman J A, Perkins D, Belger A, et al. The early stages of schizophrenia:speculation on pathogenesiology, and therapeutic approaches[J]. Biol Psychiat, 2001, 50 (16):884-897. [7] Moss Q, Fleck D E, Strakowski S M. The influence of religious affiliation on time to first treatment and hospitalization[J]. Schizophr Res, 2006, 84(2-3):421-426. [8] Chen E Y, Dunn E L, Miao M Y, et al. The impact of family experience on the duration of untreated psychosis (DUP) in Hong Kong[J]. Soc Psych Psych Epid, 2005, 40(5):350-356. [9] 孙继军, 孙裕勇, 朱春燕,等. 首发精神分裂症未治疗时间对认知功能及预后的影响[J]. 中华全科医学, 2016, 14 (1):20-23. [10] Marshall M, Husain N, Bork N, et al. Impact of early intervention services on duration of untreated psychosis:Data from the National EDEN prospective cohort study[J]. Schizophr Res, 2014, 159(1):1-6. [11] Qin H Y, Zhang J, Wang Z P, et al. Duration of untreated psychosis and clinical outcomes of first episode schizophrenia:a 4-year follow-up study[J]. Shanghai Arch Psychiat, 2014, 26 (1):42-48. [12] Schimmelmann B G, Huber C G, Lambert M, et al. Impact of duration of untreated psychosison pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort[J]. J Psychiat Res, 2008, 42(12):982-990. [13] Singh S P. Outcomemeasures in early psychosis; relevance of duration of untreated psychosis[J]. Br J Psychiatr, 2007, 50 (Suppl):s58-s63. [14] Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohortsof first-episode patients:a systematic review[J]. Arch Gen Psychiat, 2005, 62(9):975-983. [15] 胡红涛. 喹硫平对社区慢性精神分裂症患者社会功能的康复疗效研究[J]. 解放军医药杂志, 2015,27(6):70-72. [16] 马敬, 王宁. 非典型抗精神病药物阿立哌唑治疗精神分裂症40例效果观察[J]. 解放军医药杂志, 2015,27(11):110-113. [17] 何晓华, 王勇健,谢育南,等. 齐拉西酮与利醅酮治疗流浪精神分裂症患者的症状及安全性分析[J]. 中国煤炭工业医学杂志,2014,17(2):200-203. |